WakeLights

WakeLights is developing a non-invasive neurostimulation device designed to accelerate the awakening process for coma patients and reduce associated sequelae. The core technology focuses on applying electrical stimulation to specific brain regions, such as the prefrontal cortex, to promote consciousness. This approach aims to enhance the synapses of the spinoreticular pathway and increase blood perfusion and neurotrophic factors, potentially leading to faster and more complete recoveries.

The company's solution addresses the significant challenges in managing patients in comas or minimally conscious states, where current monitoring and intervention can be manual and intermittent. By providing continuous, controlled stimulation, WakeLights seeks to improve upon existing methods that include Transcranial Direct Current Stimulation (TDCS) and right median nerve stimulation, which have shown positive results in clinical settings. The market for this technology includes hospitals and rehabilitation centers that treat patients with severe brain injuries from trauma or stroke. The business model will likely involve selling the device to these healthcare institutions, possibly following an asset-light model by outsourcing manufacturing and focusing on research, development, and clinical validation.

Keywords: neurostimulation, coma recovery, traumatic brain injury, minimally conscious state, brain stimulation, transcranial direct current stimulation, TDCS, medical device, neurotechnology, patient monitoring, consciousness, brain rehabilitation, neuro-rehabilitation, electrical stimulation, ascending reticular activating system, ARAS, prefrontal cortex stimulation, neurology, critical care technology, brain injury treatment